{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:00:07Z","timestamp":1790913607625,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"SENDIMAD","award":["BECA SENDIMAD de Ayuda a la Investigaci\u00f3n en Endocrinolog\u00eda, Nutrici\u00f3n y Diabetes 2019"],"award-info":[{"award-number":["BECA SENDIMAD de Ayuda a la Investigaci\u00f3n en Endocrinolog\u00eda, Nutrici\u00f3n y Diabetes 2019"]}]},{"name":"SENDIMAD","award":["BECA SENDIMAD de Ayuda a la Investigaci\u00f3n en Endocrinolog\u00eda, Nutrici\u00f3n y Diabetes 2019"],"award-info":[{"award-number":["BECA SENDIMAD de Ayuda a la Investigaci\u00f3n en Endocrinolog\u00eda, Nutrici\u00f3n y Diabetes 2019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03228-z","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T02:02:39Z","timestamp":1666231359000},"page":"384-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test &gt;0.9\u2009\u00b5g\/dL have a higher prevalence of cardiovascular disease than those with values \u22640.9\u2009\u00b5g\/dL"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-0072","authenticated-orcid":false,"given":"Marta","family":"Araujo-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Parra Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mart\u00edn Rojas-Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"Garc\u00eda Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Gracia Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Tom\u00e9 Fern\u00e1ndez-Ladreda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Antonio","family":"Sampedro N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Higueruela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Robles L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"3228_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1530\/EJE-10-1147","volume":"164","author":"M Terzolo","year":"2011","unstructured":"M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi et al. AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164, 851\u2013870 (2011). https:\/\/doi.org\/10.1530\/EJE-10-1147","journal-title":"Eur. J. Endocrinol."},{"key":"3228_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/nejmcp065470","volume":"356","author":"WF Young","year":"2007","unstructured":"W.F. Young, The incidentally discovered adrenal mass. N. Engl. J. Med 356, 601\u2013610 (2007). https:\/\/doi.org\/10.1056\/nejmcp065470","journal-title":"N. Engl. J. Med"},{"key":"3228_CR3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175, G1\u2013G34 (2016). https:\/\/doi.org\/10.1530\/EJE-16-0467","journal-title":"Eur. J. Endocrinol."},{"key":"3228_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.endinu.2020.03.002","volume":"67","author":"M Araujo-Castro","year":"2020","unstructured":"M. Araujo-Castro, M. Iturregui Guevara, M. Calatayud Guti\u00e9rrez, P. Parra Ram\u00edrez, P. Gracia Gimeno, F.A. Hanzu et al. Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition. Endocrinol. Diabetes y. Nutr. 67, 408\u2013419 (2020). https:\/\/doi.org\/10.1016\/j.endinu.2020.03.002","journal-title":"Endocrinol. Diabetes y. Nutr."},{"key":"3228_CR5","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.4158\/EP-2020-0182","volume":"26","author":"JH Kim","year":"2020","unstructured":"J.H. Kim, Min Joo Kim, J.H. Lee, J.W. Yoon, C.S. Shin, M.J. Kim et al. Nonfunctioning adrenal incidentalomas are not clinically silent: a longitudinal cohort study. Endocr. Pr. 26, 1406\u20131415 (2020). https:\/\/doi.org\/10.4158\/EP-2020-0182","journal-title":"Endocr. Pr."},{"key":"3228_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12020-021-02741-x","volume":"74","author":"F Athanasouli","year":"2021","unstructured":"F. Athanasouli, G. Georgiopoulos, N. Asonitis, F. Petychaki, A. Savelli, E. Panou et al. Nonfunctional adrenal adenomas and impaired glucose metabolism: a systematic review and meta-analysis. Endocrine 74, 50\u201360 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02741-x","journal-title":"Endocrine"},{"key":"3228_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.endinu.2019.01.007","volume":"66","author":"R Emral","year":"2019","unstructured":"R. Emral, B.\u0130. Aydo\u011fan, A.D. K\u00f6se, \u00d6. Demir, D. \u00c7orap\u00e7\u0131o\u011flu, Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome. Endocrinol. Diabetes y. Nutr. 66, 402\u2013409 (2019). https:\/\/doi.org\/10.1016\/j.endinu.2019.01.007","journal-title":"Endocrinol. Diabetes y. Nutr."},{"key":"3228_CR8","doi-asserted-by":"publisher","unstructured":"M. Araujo-Castro Cardiometabolic profile and urinary metabolomic alterations in non-functioning adrenal incidentalomas: a review. Clin Endocrinol (Oxf) (2022). https:\/\/doi.org\/10.1111\/cen.14745","DOI":"10.1111\/cen.14745"},{"key":"3228_CR9","doi-asserted-by":"publisher","unstructured":"M. Araujo-Castro, H.F. Escobar-Morreale, P. Valderr\u00e1bano, A Proposal for Nomenclature Revision of Non-functioning Adrenal Incidentalomas as Adrenal Lesions of Undetermined Secretion of Adrenal Steroids (ALUSAS). Endocr Pract (2022). https:\/\/doi.org\/10.1016\/J.EPRAC.2022.06.007","DOI":"10.1016\/J.EPRAC.2022.06.007"},{"key":"3228_CR10","doi-asserted-by":"publisher","unstructured":"M. Araujo-Castro, P. Parra Ram\u00edrez, C. Robles L\u00e1zaro, R. Garc\u00eda Centeno, P. Gracia Gimeno, M.T. Fern\u00e1ndez-Ladreda, et al. Predictors of tumour growth and autonomous cortisol secretion development during follow-up in non-functioning adrenal incidentalomas. J Clin Med 10, (2021). https:\/\/doi.org\/10.3390\/jcm10235509","DOI":"10.3390\/jcm10235509"},{"key":"3228_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S42000-021-00308-Z","volume":"20","author":"M Araujo-Castro","year":"2021","unstructured":"M. Araujo-Castro, P.P. Ram\u00edrez, C.R. L\u00e1zaro, R.G. Centeno, P.G. Gimeno, M.T. Fern\u00e1ndez-Ladreda et al. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas. Horm 2021 20, 1\u201310 (2021). https:\/\/doi.org\/10.1007\/S42000-021-00308-Z","journal-title":"Horm 2021"},{"key":"3228_CR12","doi-asserted-by":"publisher","first-page":"E1221","DOI":"10.1210\/CLINEM\/DGAB724","volume":"107","author":"N Genere","year":"2022","unstructured":"N. Genere, R.J. Kaur, S. Athimulam, M.A. Thomas, T. Nippoldt, M. Van Norman et al. Interpretation of abnormal dexamethasone suppression test is enhanced with use of synchronous free cortisol assessment. J. Clin. Endocrinol. Metab. 107, E1221\u2013E1230 (2022). https:\/\/doi.org\/10.1210\/CLINEM\/DGAB724","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3228_CR13","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s12020-020-02455-6","volume":"70","author":"M Araujo-Castro","year":"2020","unstructured":"M. Araujo-Castro, E. Pascual-Corrales, A. Acitores Cancela, S. Garc\u00eda Duque, L. Ley Urzaiz, V. Rodr\u00edguez Berrocal, Status and clinical and radiological predictive factors of presurgical anterior pituitary function in pituitary adenomas. Study 232 patients Endocr. 70, 584\u2013592 (2020). https:\/\/doi.org\/10.1007\/s12020-020-02455-6","journal-title":"Study 232 patients Endocr."},{"key":"3228_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"P.A. Harris, R. Taylor, R. Thielke, J. Payne, N. Gonzalez, J.G. Conde, Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. 42, 377\u2013381 (2009). https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J. Biomed. Inf."},{"key":"3228_CR15","doi-asserted-by":"publisher","unstructured":"P.A. Harris, R. Taylor, B.L. Minor, V. Elliott, M. Fernandez, O\u2019Neal L., et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 95, (2019). https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"3228_CR16","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s40618-021-01539-y","volume":"44","author":"M Araujo-Castro","year":"2021","unstructured":"M. Araujo-Castro, C. Robles L\u00e1zaro, P. Parra Ram\u00edrez, R. Garc\u00eda Centeno, P. Gracia Gimeno, M.T. Fern\u00e1ndez-Ladreda et al. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas. J. Endocrinol. Invest 44, 2349\u20132357 (2021). https:\/\/doi.org\/10.1007\/s40618-021-01539-y","journal-title":"J. Endocrinol. Invest"},{"key":"3228_CR17","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.2174\/1871530320666200910110337","volume":"21","author":"O Akkus","year":"2020","unstructured":"O. Akkus, G. Akkus, O. Kaypakli, F.K. Ozturk, E. Gurkan, O. Bekler et al. Increased rates of coronary artery calcium score in patients with non - functioning adrenal incidentaloma. Endocr., Metab. Immune Disord. - Drug Targets 21, 1319\u20131325 (2020). https:\/\/doi.org\/10.2174\/1871530320666200910110337","journal-title":"Endocr., Metab. Immune Disord. - Drug Targets"},{"key":"3228_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40618-020-01360-z","volume":"44","author":"MP de Paula","year":"2021","unstructured":"M.P. de Paula, A.B. Moraes, M. de Souza, G.C. das, E.M.R. Cavalari, R.C. Campbell, G. Fernandes, S. da et al. Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed. J. Endocrinol. Invest 44, 609\u2013619 (2021). https:\/\/doi.org\/10.1007\/s40618-020-01360-z","journal-title":"J. Endocrinol. Invest"},{"key":"3228_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/S12020-020-02212-9","volume":"68","author":"V Morelli","year":"2020","unstructured":"V. Morelli, C. Aresta, A. Gaudio, C. Eller-Vainicher, V.V. Zhukouskaya, D. Merlotti et al. Prediction of hypertension, diabetes and fractures in eucortisolemic women by measuring parameters of cortisol milieu. Endocrine 68, 411\u2013419 (2020). https:\/\/doi.org\/10.1007\/S12020-020-02212-9","journal-title":"Endocrine"},{"key":"3228_CR20","doi-asserted-by":"publisher","unstructured":"M. Parasiliti-Caprino, C. Lopez, M. Bollati, F. Bioletto, C. Sola, M.C. Di Carlo, et al. A retrospective study on the association between urine metanephrines and cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma. Sci Rep 12, (2002). https:\/\/doi.org\/10.1038\/S41598-022-19321-2","DOI":"10.1038\/S41598-022-19321-2"},{"key":"3228_CR21","doi-asserted-by":"publisher","unstructured":"M. Araujo-Castro, G. Casals, F.A. Hanzu, E. Pascual-Corrales, A.M. Garc\u00eda Cano, V.F. Lanza, et al. Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study. Clin Endocrinol (Oxf) 2022. https:\/\/doi.org\/10.1111\/CEN.14811","DOI":"10.1111\/CEN.14811"},{"key":"3228_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/S00508-021-01909-9","volume":"134","author":"I Karahan","year":"2022","unstructured":"I. Karahan, S. Durmaz Ceylan, A. Gungunes, A. Cifci, F. Eker, U. Kisa, Non-functioning adrenal incidentalomas may increase toxic metabolites. Wien. Klin. Wochenschr. 134, 125\u2013129 (2022). https:\/\/doi.org\/10.1007\/S00508-021-01909-9","journal-title":"Wien. Klin. Wochenschr."},{"key":"3228_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-2796.2010.02291.x","volume":"268","author":"M Peppa","year":"2010","unstructured":"M. Peppa, C. Koliaki, S.A. Raptis, Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications. J. Intern Med 268, 555\u2013566 (2010). https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02291.x","journal-title":"J. Intern Med"},{"key":"3228_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12020-020-02476-1","volume":"71","author":"P Falcetta","year":"2020","unstructured":"P. Falcetta, F. Orsolini, E. Benelli, P. Agretti, P. Vitti, C. Di Cosmo et al. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study. Endocrine 71, 178\u2013188 (2020). https:\/\/doi.org\/10.1007\/s12020-020-02476-1","journal-title":"Endocrine"},{"key":"3228_CR25","doi-asserted-by":"publisher","unstructured":"M. Araujo\u2010Castro, G. Casals, F.A. Hanzu, E. Pascual\u2010Corrales, A.M. Garc\u00eda Cano, V.F. Lanza, et al. Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study. Clin Endocrinol (Oxf) (2022). https:\/\/doi.org\/10.1111\/CEN.14811","DOI":"10.1111\/CEN.14811"},{"key":"3228_CR26","doi-asserted-by":"publisher","unstructured":"N. Muangnoo, W. Manosroi, N. Leelathanapipat, T. Meejun, P. Chowchaiyaporn, P. Teetipsatit Predictive Factors of Functioning Adrenal Incidentaloma: A 15-Year Retrospective Study. Med 2022 58. https:\/\/doi.org\/10.3390\/MEDICINA58050597\/S1","DOI":"10.3390\/MEDICINA58050597\/S1"},{"key":"3228_CR27","doi-asserted-by":"publisher","unstructured":"L. Barzon, C. Scaroni, N. Sonino, F. Fallo, A. Paoletta, M. Boscaro Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas 1. J Clin Endocrinol Metab (1999). https:\/\/doi.org\/10.1210\/jcem.84.2.5444","DOI":"10.1210\/jcem.84.2.5444"},{"key":"3228_CR28","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2265.2010.03963.x","volume":"74","author":"DA Vassiliadi","year":"2011","unstructured":"D.A. Vassiliadi, G. Ntali, E. Vicha, S. Tsagarakis, High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management. Clin. Endocrinol. (Oxf.) 74, 438\u2013444 (2011). https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03963.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3228_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1530\/EJE-13-0848","volume":"171","author":"E Vassilatou","year":"2014","unstructured":"E. Vassilatou, A. Vryonidou, D. Ioannidis, S.A. Paschou, M. Panagou, I. Tzavara, Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications. Eur. J. Endocrinol. 171, 37\u201345 (2014). https:\/\/doi.org\/10.1530\/EJE-13-0848","journal-title":"Eur. J. Endocrinol."},{"key":"3228_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12020-012-9622-2","volume":"42","author":"H Olsen","year":"2012","unstructured":"H. Olsen, E. Nordenstr\u00f6m, A. Bergenfelz, U. Nyman, S. Valdemarsson, E. Palmqvist, Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden. Endocrine 42, 164\u2013173 (2012). https:\/\/doi.org\/10.1007\/s12020-012-9622-2","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03228-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03228-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03228-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T03:41:59Z","timestamp":1675309319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03228-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["3228"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03228-z","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"9 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the Hospital Universitario Ram\u00f3n y Cajal. Madrid. Spain (approval date: 23 September 2019, acta CEIm 10\/19, approval number: 3702)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Patient consent was waived due to the retrospective nature of the study. Only for patients who continued follow-up or prospectively included the informed consent was requested.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}